| Estimation of stature from measurements of long bones, hand and foot dimensions BG Chikhalkar, AA Mangaonkar, SD Nanandkar, RG Peddawad J Indian Acad Forensic Med 32 (4), 329-33, 2010 | 141 | 2010 |
| Inverse association of telomere length with liver disease and mortality in the US population P Rattan, DD Penrice, JC Ahn, A Ferrer, M Patnaik, VH Shah, PS Kamath, ... Hepatology communications 6 (2), 399-410, 2022 | 103 | 2022 |
| Short telomere syndromes in clinical practice: bridging bench and bedside AA Mangaonkar, MM Patnaik Mayo Clinic Proceedings 93 (7), 904-916, 2018 | 92 | 2018 |
| Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study … G Coltro, AA Mangaonkar, TL Lasho, CM Finke, P Pophali, R Carr, ... Leukemia 34 (5), 1407-1421, 2020 | 82 | 2020 |
| Clinical heterogeneity of the VEXAS syndrome: a case series MJ Koster, T Kourelis, KK Reichard, TA Kermani, DB Beck, DO Cardona, ... Mayo Clinic Proceedings 96 (10), 2653-2659, 2021 | 77 | 2021 |
| Blinatumomab-induced lineage switch of B-ALL with t (4: 11)(q21; q23) KMT2A/AFF1 into an aggressive AML: pre-and post-switch phenotypic, cytogenetic and molecular analysis CL Haddox, AA Mangaonkar, D Chen, M Shi, R He, JL Oliveira, ... Blood cancer journal 7 (9), e607-e607, 2017 | 66 | 2017 |
| Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients T Coston, P Pophali, R Vallapureddy, TL Lasho, CM Finke, RP Ketterling, ... American journal of hematology 94 (7), 767-779, 2019 | 64 | 2019 |
| Idelalisib: a novel PI3Kδ inhibitor for chronic lymphocytic leukemia A Shah, A Mangaonkar Annals of Pharmacotherapy 49 (10), 1162-1170, 2015 | 60 | 2015 |
| RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis RM Carr, D Vorobyev, T Lasho, DL Marks, EJ Tolosa, A Vedder, ... Nature communications 12 (1), 2901, 2021 | 52 | 2021 |
| Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia MM Patnaik, DA Sallman, AA Mangaonkar, R Heuer, J Hirvela, ... Blood, The Journal of the American Society of Hematology 136 (7), 909-913, 2020 | 47 | 2020 |
| Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt … AA Mangaonkar, DM Swoboda, G Coltro, TL Lasho, PJ Novotny, ... Leukemia 34 (2), 656-661, 2020 | 43 | 2020 |
| Spectrum of clonal hematopoiesis in VEXAS syndrome F Gutierrez-Rodrigues, Y Kusne, J Fernandez, T Lasho, R Shalhoub, ... Blood, The Journal of the American Society of Hematology 142 (3), 244-259, 2023 | 38 | 2023 |
| A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2, 3 dioxygenase expression A Mangaonkar, AK Mondal, S Fulzule, C Pundkar, EJ Park, A Jillella, ... Scientific reports 7 (1), 12892, 2017 | 38 | 2017 |
| Hereditary predisposition to hematopoietic neoplasms: when bloodline matters for blood cancers AA Mangaonkar, MM Patnaik Mayo Clinic Proceedings 95 (7), 1482-1498, 2020 | 35 | 2020 |
| Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms HB Alkhateeb, A Nanaa, D Viswanatha, JM Foran, T Badar, L Sproat, ... Blood advances 6 (2), 528-532, 2022 | 33 | 2022 |
| Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN … EC DiFilippo, G Coltro, RM Carr, AA Mangaonkar, M Binder, SP Khan, ... Leukemia 34 (9), 2519-2524, 2020 | 30 | 2020 |
| Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation X You, F Liu, M Binder, A Vedder, T Lasho, Z Wen, X Gao, E Flietner, ... Blood, The Journal of the American Society of Hematology 139 (7), 1066-1079, 2022 | 27 | 2022 |
| Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia P Pophali, A Matin, AA Mangaonkar, R Carr, M Binder, A Al-Kali, ... Blood cancer journal 10 (11), 121, 2020 | 27 | 2020 |
| Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts AA Mangaonkar, N Gangat, A Al-Kali, MA Elliott, KH Begna, CA Hanson, ... Leukemia research 71, 60-62, 2018 | 26 | 2018 |
| Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia N Gangat, I Johnson, K McCullough, F Farrukh, A Al-Kali, H Alkhateeb, ... Haematologica 107 (10), 2501, 2022 | 25 | 2022 |
